A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.

Rampling, R, Peoples, S, Mulholland, PJ et al. (17 more authors) (2016) A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research, 22 (19). pp. 4776-4785. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
  • Rampling, R
  • Peoples, S
  • Mulholland, PJ
  • James, A
  • Al-Salihi, O
  • Twelves, CJ
  • McBain, C
  • Jefferies, S
  • Jackson, A
  • Stewart, W
  • Lindner, J
  • Kutscher, S
  • Hilf, N
  • McGuigan, L
  • Peters, J
  • Hill, K
  • Schoor, O
  • Singh-Jasuja, H
  • Halford, SE
  • Ritchie, JWA
Copyright, Publisher and Additional Information: © 2016 American Association for Cancer Research. This is an author produced version of a paper published in Clinical Cancer Research. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 11 May 2016
  • Published (online): 25 May 2016
  • Published: 1 October 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Oct 2016 08:51
Last Modified: 02 Jul 2017 12:12
Published Version: https://dx.doi.org/10.1158/1078-0432
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1078-0432
Related URLs:

Share / Export

Statistics